Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome

Yaron Shapira*, Felix Mor, Avri Friedler, Arjeh J. Wysenbeek, Abraham Weinberger

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

A 22 year old woman presented with lupus nephritis, hypertension, and intractable nephrotic syndrome. Albumin and furosemide given intravenously was ineffective. Captopril administered in a daily dose of 62 5 mg was associated with a reduction in proteinuria from 28 g/24 hours to 11-5 g/24 hours over 10 weeks, resulting in a weight reduction of 16 kg. This was achieved with relative preservation of renal function. Captopril should be considered in the treatment of intractable proteinuria in patients with lupus nephritis, or when cytotoxic drugs are refused, because of its efficacy and relative safety. Captopril should, however, be used as an adjunct and not as a substitute for standard treatment.

Original languageEnglish
Pages (from-to)725-727
Number of pages3
JournalAnnals of the Rheumatic Diseases
Volume49
Issue number9
DOIs
StatePublished - 1990

Fingerprint

Dive into the research topics of 'Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome'. Together they form a unique fingerprint.

Cite this